Group 1 - The establishment of the UK subsidiary and EU medical center in Stoke-on-Trent marks a significant step in the company's localization strategy in the European market, providing efficient orthodontic medical support and services to regional cooperating doctors [1][3] - The new center follows the company's previous expansions in Germany, France, and the automated production base in Spain, creating a collaborative system in Europe that integrates research and development, production, medical design, and services [3] - The Stoke-on-Trent center will focus on providing customized orthodontic solution design, case analysis, and technical support to dental practitioners in Europe, ensuring services align with local clinical practices and regulatory standards [3] Group 2 - The UK team will leverage over 20 years of technical expertise in invisible orthodontics and jaw reconstruction to develop targeted solutions based on clinical needs in the European market [3] - The center aims to collaborate with local dental institutions and academic organizations for in-depth technical research and innovation in clinical applications of invisible orthodontics [3] - The founder and CEO emphasized that the UK is one of the most dynamic medical and research markets in Europe, and the new center enhances regional service capabilities while providing high-quality localized support to more European doctors and patients [3]

Investment Rating - The report maintains a "Buy" rating for the company, expecting a price increase of over 15% in the next 6-12 months [5]. Core Insights - The company achieved a revenue of $16.14 million in H1 2025, representing a year-on-year growth of 33.1%. Net profit reached $1.42 million, up 583.6%, while adjusted net profit was $1.95 million, growing by 84.8% [2]. - The rapid growth of overseas business has become a core driver, with revenue from global markets outside mainland China reaching $7.1 million, a 123% increase year-on-year. Domestic revenue slightly increased to $8.97 million. The total case count for H1 2025 was 225,800, up 47.7% [3]. - The company is focusing on enhancing R&D capabilities, increasing investments in IT, legal, and operational teams, optimizing legal services, expanding production capacity, and broadening its sales network to strengthen its global market presence [4]. Financial Performance Summary - The company forecasts net profits for 2025-2027 to be $1.2 million, $1.9 million, and $2.4 million, respectively, with growth rates of 1.85%, 53.03%, and 27.37%. The expected EPS for the same period is $0.072, $0.111, and $0.141, with corresponding P/E ratios of 133, 87, and 68 [5][9].